AMA TONG

Healthcare Portfolio · Uganda

Four lines.
One standard.

A staged institutional portfolio built around recurring healthcare needs, quality-assured sourcing, dependable delivery and support that matches the product.

Quality products. Reliable access. Stronger healthcare.

Portfolio position

Focused enough to deliver. Structured to grow responsibly.

AMA TONG Medical LLP sources and distributes selected healthcare products for institutional buyers. Categories are introduced in stages: a product line opens only when demand, authorization, supplier qualification, storage, delivery and post-supply support can be demonstrated.

Foundation lineStaged lineStaged specialist line

01 · Portfolio architecture

Four connected healthcare lines.

The examples below describe intended scope, not a claim that every listed product is currently stocked or authorized.

01 · Foundation lineCORE

Core Essentials

High-frequency products supporting routine healthcare delivery and institutional continuity.

  • Syringes, needles and selected injection supplies
  • IV fluids, administration sets and related consumables
  • Examination and surgical gloves
  • Masks, gowns and selected infection-prevention products
  • Gauze, dressings and routine wound-care supplies
  • Specimen, waste and sharps-management products
  • Selected routine diagnostic and laboratory consumables

Activation requirement: compliant sourcing, traceability, storage readiness and dependable recurring supply.

02 · Staged lineTECH

Clinical Technology

Fit-for-purpose equipment introduced with the technical arrangements needed to support safe use.

  • Vital-sign and multiparameter monitoring
  • Portable ultrasound and Doppler devices
  • Oxygen concentrators and suction equipment
  • Emergency-care and selected resuscitation equipment
  • Maternal, newborn and paediatric equipment
  • Selected examination, patient-care and facility equipment

Activation requirement: written authorization where applicable, installation, warranty, calibration, servicing and user orientation.

03 · Staged lineNUTRITION

Nutrition & Dietary Management

Nutrition products and dietary-management supplies for defined institutional and programme needs.

  • Dietary nutrition supplements
  • Maternal and paediatric dietary support products
  • Micronutrient and vitamin products
  • Oral rehydration and electrolyte products
  • Dietary-management products for selected institutional uses
  • Institutional nutrition and dietary-practice resources

Activation requirement: clear product classification, quality documentation, appropriate professional guidance, suitable storage and confirmed institutional demand.

04 · Staged specialist linePUBLIC HEALTH

Public Health & Specialist Support

Programme commodities and technical support systems introduced where institutional public-health delivery requires them.

  • Selected public-health programme commodities
  • Outreach and programme-support kits
  • Cold-chain carriers, storage and temperature monitoring where required
  • Selected point-of-care and field-support systems
  • Product-use orientation and programme implementation support
  • Professional-development resources linked to responsible product use

Activation requirement: confirmed programme need, regulatory clarity, specialist competence, technical support, service arrangements and dependable supply continuity.

02 · Institutional audiences

Designed for organizations responsible for healthcare delivery.

AMA TONG's public portfolio is business-to-business and institutional. It is not presented as a direct-to-patient catalogue.

01

Hospitals & Clinics

Routine supplies, clinical technology and facility-level product support.

02

Government Health Institutions

Commodities and institutional supply aligned with applicable procurement requirements.

03

NGOs, UN & Development Partners

Programme-based medical and dietary nutrition supply.

04

Licensed Distribution Partners

Appropriately regulated pharmacy, laboratory and distribution relationships.

03 · Portfolio gate

Six questions before a category opens.

Every new category must pass the same evidence gate. This protects buyers, partners and AMA TONG from premature commitments.

01

Demand

Is a defined institutional need confirmed?

02

Authorization

Are classification, registration and distribution pathways clear?

03

Quality

Can manufacturer, product and batch documentation be verified?

04

Supply

Are sourcing, storage, traceability and delivery dependable?

05

Support

Can training, warranty, servicing or calibration be assured?

06

Economics

Can the line operate sustainably without fixed promises?

04 · Delivery standard

Support should match the product.

A consumable, diagnostic device and dietary-management product do not require the same controls. AMA TONG scales responsibility with product complexity.

Knowledge translation informs assessment, specification and support. When a performance gap appears, fishbone analysis helps identify root causes; KAIZEN turns the findings into practical improvements. The Theory of Change keeps the intended contribution realistic and measurable.

01AssessNeed and context
02SpecifyFit and standards
03SourceQualified supply
04DeliverTraceable logistics
05SupportUse and continuity
06ImproveFeedback and review

05 · Professional capability

Capability travels with the product.

Professional development may cover responsible product use, quality of care, patient safety, evidence-based practice, professionalism, nutrition and dietary management, and responsible AI use in clinical settings. Training is described as professional development unless separately accredited or approved.

Clear boundary

AMA TONG supplies healthcare products and provides professional education. It does not present this portfolio as clinical care, prescribing, diagnosis or patient-specific dietary treatment.

Institutional enquiries

Start with the requirement, not the catalogue.

Share the product specification, quantity, delivery location, required documentation and intended use. AMA TONG will confirm availability, authorization pathway, support requirements and commercial terms before making a commitment.

contact@amatongmedical.com

Availability of every product remains subject to applicable authorization, supplier qualification and confirmed operational capacity. No clinical or regulatory outcome is guaranteed.